// App-Quantinova.ai

3664 : A workflow to evaluate PD-L1 protein expression on circulating tumor cells (CTCs) from non-small cell lung cancer (NSCLC)

Researchers

Presenter

  • Corinne Renier

Principal Investigators

  • Charles L. Wilkerson

  • SJ Claire Hur

  • Da Eun Rachel Park

  • Clementine A. Lemaire

  • Melissa Matsumoto

  • James Carroll

  • Steve Crouse

  • Jonathan W. Goldman

  • Edward B. Garon

  • Dino Di Carlo

  • Elodie Christen-Sollier

Medical Centers

  • 3-V Biosciences Inc, Menlo Park, CA

  • University of California, Los Angeles, Los Angeles, CA

  • UCLA David Geffen School of Medicine, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved